ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Role of PARP Inhibitors in Prostate Cancer

Christopher E. Barbieri, MD, PhD
Published Online:12:54 PM, Tue August 9, 2016

Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and New-York Presbyterian, discusses the role of PARP inhibitors in castration-resistant prostate cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.